ACUTE UNDIFFERENTIATED LEUKEMIA
Clinical trials for ACUTE UNDIFFERENTIATED LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE UNDIFFERENTIATED LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE UNDIFFERENTIATED LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo before transplant may stop blood cancer return
Disease control Recruiting nowThis study tests a new approach for adults with aggressive blood cancers (like AML) that are hard to treat. Patients get a stronger chemotherapy mix (decitabine plus FLAG-Ida) and total body radiation, followed by a donor stem cell transplant. The goal is to kill cancer cells and…
Matched conditions: ACUTE UNDIFFERENTIATED LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:11 UTC
-
New approach aims to stop Graft-Versus-Host disease in young cancer patients
Disease control Recruiting nowThis study tests whether removing a specific type of immune cell (naive T cells) from donated stem cells can prevent chronic graft-versus-host disease (GVHD) in children and young adults with blood cancers. GVHD occurs when donor cells attack the patient's body, causing long-term…
Matched conditions: ACUTE UNDIFFERENTIATED LEUKEMIA
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:55 UTC
-
Could bone marrow from deceased donors offer a new lifeline for blood cancer patients?
Disease control Recruiting nowThis early-phase study is testing whether bone marrow from deceased donors can be safely used for transplants in people with blood cancers like leukemia and lymphoma. About 12 patients will receive either strong or milder chemotherapy before the transplant. Researchers will monit…
Matched conditions: ACUTE UNDIFFERENTIATED LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Ossium Health, Inc. • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Engineered immune cells take aim at returning leukemia
Disease control Recruiting nowThis early-phase trial tests a new treatment for children and adults with acute leukemia that has come back or not responded after a donor stem cell transplant. The treatment uses specially engineered immune cells (T cells) from the original donor that are trained to recognize an…
Matched conditions: ACUTE UNDIFFERENTIATED LEUKEMIA
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 18, 2026 12:03 UTC